Jungova A, Stork M, Spicka I, Radocha J, Minarik J, Pavlicek P, Mihalyova J, Pour L, Straub J, Maisnar V, Pika T, Dekojova T, Soukup J, Popkova T, Mensikova K, Sedlák F, Pospiskova J, Boichuk I, Krhovska P, Stopka T, Jindra P, Jelínek T, Knechtová Z, Capounova V, Latal V, Muronova L, Heindorfer A, Ullrychova J, Sykora M, Kessler P, Hajek R. P25 | REAL-WORLD OUTCOMES IN NEWLY DIAGNOSED MULTIPLE MYELOMA: EVIDENCE SUPPORTING BORTEZOMIB–LENALIDOMIDE–DEXAMETHASONE AS A PREFERRED REGIMEN WITHOUT ANTI-CD38 ANTIBODIES. Haematologica 2026; 111(s2); https://doi.org/10.3324/haematol.2026.s2.14036.